Conference Room

Workshop Room

Conference Room

Regulation, Legislation & Research

09:00-09:10

Conference Inauguration - Welcome Remarks

09:10-09:20

A Maltese vision

The small island nation is intent on taking the medical cannabis industry head on. What steps are being taken to ensure that it’s a success?

Hon. Chris Cardona

09:20-09:30

The European standpoint

Ladies and gentlemen, please give a warm welcome to European parliamentarian, Miriam Dalli, as she elucidates her thoughts on this fast-growing space.

Hon. Miriam Dalli

09:30-10:10

The Future of CBD in Europe

The emergence of CBD is driving product innovation for consumers seeking wellness benefits associated with it. Let’s take a third person view and look into shifting market regulations on cannabis extracts and the state of health product supply chains at an EU level.

Richard Sharp

Cobidol

Jon Liebling

Henri Sant-Cassia

Sana-Ara Ahmed

Stephen Oliver

Dave Charnick

Ben Wilson

10:10-10:20

Next steps: research & development for medical cannabis

How has Malta’s recent legal push on medical cannabis front affected R&D targets within scientific community?

Hon. Deo Debattista

10:20-10:30

Malta Enterprise and medical cannabis

An overview of Malta Enterprise’s function within the lifesciences sector.

Marion Zammit

10:30-10:45

From Tragedy to Triumph

An inspirational story characterised by one mother’s journey to find a cure.

Tracy Ryan

10:45-11:00

The medical cannabis business proposition

What steps does a company need to take to operate a successful medical cannabis sector?

Yona Levy

Alvit LCS Pharma
11:00-11:10

An alternative way

Let’s analyse a compelling argument for boosting the body’s natural endocannabinoids.

 

 

Giuseppe Di Giovanni

11:10-11:20

Sex differences in cannabinoid-related behaviour

Can the hormone-driven differentiation of the brain endocannabinoid system represent a biological basis for male-female differences in cannabinoid sensitivity? Let’s find out.

Liana Fattore

11:10-11:20

R&D: inspecting the endocannabinoid and central nervous system

Let’s dive into a retrospective analysis on the interplay between human-biological systems.

Laszlo Mechtler

11:20-11:40

Pioneering white space for brands

How do we use data-science to distill irrifutable human insights and forge a brand narrative in a rapidly evolving market?

Anthony Wolch

Beyond Marketing Group
11:40-11:50

Going International: a new frontier for medical cannabis

As the medical cannabis industry expands, the expectation of an international regulatory framework and policy formation grows with it. What would a global approach look like?

Marcus Ramkissoon

11:50-12:00

Transitioning from principles to practice

How can we maximise accurate and efficient clinical research while also improving patient benefit?

Anne Katrin Schlag

12:00-12:10

Challenging the Status Quo: A Case for Mainstream Cannabis Healthcare

Accurate medical cannabis data compiled with proprietary patient registry software is set to improve decision making from both a regulatory and practitioner’s perspective. Let’s dive head first into this innovative solution.

Prad Sekar

12:10-12:20

Real of artificial? The case for synthetic cannabinoids

What are the benefits and disadvantages of man-made cannabinoids?

Manit Patel

12:20-12:30

Medical Malta: a regulatory update

What can Malta learn from the various regulatory approaches championed forward-looking nations?

Alexander Pombo

Nerum Pharmaceuticals

Start-up Pitch

Investment Opportunities

14:00-14:10

Investment Landscape

What investors look for in this sector.

Nick Tulloch

14:10-14:30

Hemp VS. non-hemp cannabis: Alpha through the vapor

It’s time to explore the immense social, medical and economic impact this budding sector will have on the world at large.

Sumit Mehta

Monica Vialpando

Nicole Fox

14:30-14:40

Your medical cannabis business in Malta

Time to present the nuts and bolts guide to establishing your business in medical Malta.

Gianluca Caruana Curran

14:40-14:50

Safe and legal: from disruption to mainstream adoption

What was once a disruptive market is now emerging as an accepted mainstream medical product. Let’s dive into the use-cases.

Vladas Snieckus

14:50-15:10

Emerging markets: a cross-continent comparison

How is the Asian market progressing in the medical cannabis industry and what future developments are expected?

Brian Sheng

15:10-15:20

Cannabis in the US: an industry overview

Let’s get an overall sense of this growing market, its potential for development and the impact of legislative changes at both the state and federal level.

William J. Pascrell, III

15:20-15:40

Venture capital, fund restrictions and startups

Injecting capital into crop cultivation, emerging technology and medical cannabis services can be cumbersome within a hesitant capital environment. How can startups get the funds they need to push onwards?

Isabel Fox

Mark Hamade

Baran Dilaver

Jason Corbett

15:40-15:50

Real estate investment opportunities

How does a prospective entrepreneur plan the acquistion, design and construction of a medical cannabis facility?

Daniel Sax

15:50-16:00

New horizons: pharmaceutical cannabis opportunities

How can cannabis be applied to the pharmaceutical industry?

Steele Clark Smith III

16:00-16:10

Ancillary Services

What kinds of ancillary businesses are needed to support and grow the medical cannabis sector?

Anuj Desai

16:10-16:20

From farm to pharma: Israel's experience

Clinical trials of medical cannabis sector have proven to be successful in Israel. How does this compare to the EU?

Golan Bitton

UNIVO
16:20-16:40

Medical Malta: the medical cannabis island

Let’s analyse the plethora of reasons to setup your business in sunny Malta.

Gianluca Caruana Curran

Christopher Emms

Green Goblin
16:40-16:50

US venture capital: a process overview

How does one raise capital while maintaining compliance with state, federal and FDA regulations?

Dave Rodman

16:50-17:00

The hemp opportunity

Serious investors in the medical cannabis industry must look at a diversified portfolio to minimise risk and maximise returns. Let’s take a look at China’s CBD impact on the global market.

Sumit Mehta

17:00-17:10

Canada's pearls and pitfalls

What does the Canadian market look like one year after legalisation? Does this regulatory framework address today’s needs?

Jaspreet Grewal

17:10-17:30

VC's and PE

Venture capitalists and private equity funds are heavily involved in the North American medical cannabis market. How does this compare to Europe?

Matthew Nordgren

17:30-17:40

Left behind? The pitfalls of traditional financing models

How is stigma and uncertainty preventing medical cannabis companies from raising capital through banks and lending institutions?

Mark Hamade

17:40-17:50

Market analysis: trends and expectations

The global impact of evolving medical cannabis markets.

Kris Krane

17:50-18:00

Seeing eye to eye: society and investors

As investment firms look for more socially responsible projects to put their money, how is the medical cannabis industry benefiting?

Workshop Room

Emerging Medical Cannabis Markets expand icon

09:00-09:30

GERMANY

How the industry is tackling demand outstripping supply and conservatism amongst healthcare professionals.

Linus Maximilian Weber

09:30-10:00

Malta

Andrew Agius

10:00-10:30

United Kingdom

What are the main obstacles facing the UK in the early stages of the legalized medical cannabis industry? main obstacles facing the UK in the early stages of the legalized medical cannabis industry?

Dani Gordon

10:30-11:00

Thailand

Thailand 4.0 initiative, ethical issues and the role of educational institutes.

Suttisak Jantavongso

11:00-11:30

Switzerland

11:30-12:00

ITALY

12:00-12:30

GREECE

12:30-13:00

Australia

Established Medical Cannabis Markets expand icon

14:00-14:30

Uruguay

14:30-15:00

North America

The importance of the Hemp plant going forward in the medical cannabis industry.

Preet Marwaha

15:00-15:30

Jamaica

How the medical cannabis export industry and tourism are helping to create jobs for rural farmers along with other benefits for different parts of the supply chain.

Lakisha Jenkins

15:30-16:00

CALIFORNIA

How this pioneering market was established by different drivers, both the innovative and the highly regulated; is nanny state regulation the answer to the stigma?

Constance Finley

16:00-16:30

United States

How is the US leading the way on clinical studies and research into the benefits of medical cannabis?

William J. Pascrell, III

16:30-17:00

Jamaica

Outdoor Cultivation as a Sustainable Business Model.

Markus Hoffmann

Conference Room

Social Impact & Education

09:00-09:10

Opening remarks

Ladies and gentlemen, please give a warm welcome to the deputy Prime Minister of Malta, the Hon. Chris Fearne, as he shares his thoughts on the medical cannabis sector in Malta.

Hon. Chris Fearne

09:10-09:30

Patient-led industry change

How did Hannah Deacon push for legislative change in the UK and what was the outcome of her persistent efforts?

Hannah Deacon

Michael Barnes

09:30-09:50

Cannabis education: a public approach

What sort of public awareness campaigns are needed to de-stigmatize medical cannabis and give appropriate information on the available options?

Maya Elisabeth

Basia Zieniewicz

Robin  Emerson

William Levine

Moritz Foerster

09:50-10:10

Social impact in North America

The social impact sweeping across North America and mainland Europe is undeniable. How might this develop in the near future?

Jim Walsh

Maya Elisabeth

Alix Hadley

Anthony Bailey

10:10-10:30

Psychological well-being: the case for mental health

Managing and treating mental health disorders with medical cannabis isn’t at all unheard of. Let’s discuss the insights for all to hear

Shira Adler

Jon Liebling

10:30-10:40

CBD in the UK: a deeper look into the supplements market

How is the the lack of enforcement regarding the supplements market negatively affecting public perception of the cannabinoid industry? What’s to be done on this front?

Matt Lawson

10:40-11:00

Cannabis use-cases: educating medical professionals

What are the most effective ways of passing on information to medical professionals and practitioners in the health sector?

Michael Miller

Dani Gordon

Julie Moltke

Sandra Carrillo

Cathleen Graham

11:00-11:20

The homegrown approach

Let’s look at the case for and against the regulation of private medical cannabis cultivation for chronic pain management.

Carly Barton

11:20-11:40

Psychiatric Diseases

The (endo)cannabinoid system and psychiatric diseases.

Mauro Maccarrone

11:40-12:00

Marketing the green mile

How do CBD marketing agencies get products into the hands of consumers while abiding by regulatory and payment procedures?

Richard Skaife

Cobichain
12:00-12:20

Battle of the Jurisdictions

In this animated discussion, legal experts from various jurisdictions will go head to head in explaining which state is leading the way with regulatory innovation.

Joe Rogoway

Daniel Torres Gonçalves

Dylan Kennett

12:20-12:30

A European harmonisation approach

What initiatives are in place for the harmonisation of licensing medical cannabis across Europe?

Gabriel Micallef

12:30-12:40

Enhancing recovery systems for Athletes

Medical cannabis can be used to aid in the recovery process while also acting as effective pain relief for injured athletes. Let’s dive in.

Jean-Martin Gauthier

12:40-12:50

CBD regulation: opportunities and challenges

Social, regulatory and economic hurdles fly in the face of a comprehensive global CBD regulatory framework. Is there a common denominator cross-culturally?

Marija Obradovic

12:50-13:00

Supporting women's health through medical cannabis

It’s time to highlight the importance of advocating for better medical cannabis policies to support women’s reproductive and general health.

Halima Al-Hatimy

13:00-13:20

Treating PTSD with CBD

How is medical cannabis being effectively used for the management of PTSD?

Mark Braunstein

13:20-13:30

Medical cannabis in Malta

Let’s look at the past, present and future of the medical cannabis sector in the small island nation in the heart of the Mediterranean.

Andrew Agius

13:30-13:40

R&D: inspecting the endocannabinoid and central nervous system

Let’s dive into a retrospective analysis on the interplay between human-biological systems.

Laszlo Mechtler

13:40-13:50

The missing link: memory acquisition and emotion

Is the endocannabinoid system an emotional buffer for stressful memories? Let’s find out.

Patrizia Campolongo

13:50-14:00

How safe is medical cannabis?

With all things drug-related, a level-headed and objective risk-benefit analysis is emininently desirable. Fasten your seatbelts for this rapid fire presentation.

Linda Klumpers

Technology & Security

14:00-14:20

Cross-polination: how blockchain and cannabis are a match made in heaven

How will blockchain disrupt this sector and transform it into a more lucrative and competitive endeavour?

Alex Cahana

Felix Mago

Gene Deyev

14:20-14:30

The black market: empowerment through denial?

Pretending to ignore the udnerground epidemic is just kicking the cannabis can down the road. Let’s hear what an expert-former CIA profiler has to say about that.

Alex Shah

14:30-14:40

From cultivation to waste disposal

How is Malta preparing to address environmental requirements in this growing sector?

Oliver Fenech

14:40-15:10

An honest look at deep tech in a growing market

How are US-driven tech innovations facilitating progress in this fast-paced industyr?

Jacquie Cohen Roth

Michael Patterson

Monica Vialpando

15:10-15:20

Prescriptions, fraud and patient privacy

How do we secure medical records to prevent fraud while maintaining patient privacy in the era of large-scale tech innovations?

Neil Stansbury

15:20-15:30

Medical cannabis: the scientific perspective

What does the science tell us about cannabinoid-based medicine?

Dmytro Isaev

15:30-15:40

Peering across the field: large-scale cultivation and extraction

What are the best practices for the design, build and marketing of cultivation and extraction facilities in Israel, US and Canada?

Adam Shuster

15:40-15:50

Cannabis 2.0

What does the future hold for and emerging cannabis market? Let’s dig in.

Zeid Mohamedali

15:50-16:00

Going global: a regulatory no brainer

Let’s analyse the case for building a culture of quality and GMP compliance.

Laleh Bighash

16:00-16:10

Addressing the security risk

What can Malta learn about security from international growers?

Yosi Sherman

16:10-16:20

The disruptive nature of medical cannabis technology

It’s time to bridge the gap between medical professionals and mainstream audiences on the medical cannabis front.

Pamela Hadfield

16:20-16:30

Next steps: a generational medical shift

How do we develop the next generation of medical and scientifically-backed cannabis technology?

William Levine

16:30-16:40

Setting the standard: quality over quantity

How are ISO and EU standards for vaping technology driving the industry’s quality control measures forward?

Arnaud Dumas de Rauly

16:40-16:50

The Cryptocurrency solution

Cryptocurrency can help lower costs, improve user experience, lower security risks, and increase overall efficiency. Let’s explore how cryptocurrency can solve many of the problems medical cannabis businesses face.

Felix Mago

16:50-17:10

The effect of regulation on growth and cultivation

Those in the industry appreciate the complexity of cannabis as a source of active pharmaceutical ingredients for the medicinal drug industry. Let’s extraplote further.

Sharan Sidhu

17:10-17:30

Transposition stability to maintain consistency in the cannabinoid market

Jumping genes also known as transposons are sensitive to even the smallest environmental changes. Let’s take a look at the importance of secondary metabolites to sustain micro-macro environmental stressors.

Srinivasa Reddy

17:30-17:40

Compounds VS. components: amplifying cannabinoids with Terpenes

Time for a brief overview on the boosting effects of aromatic and pharmaceutically active compounds on their isolates.

 

 

Neville Edel

17:40-17:50

Dry powder inhalers

A clean alternative to smoking and vaping

Andreas Boeckl

Workshop Room

Seed-to-patient Tracking with Blockchain Technology expand icon

09:00-09:30

How is blockchain technology revolutionising the medical cannabis supply chain?

Petar Savic

Supreme Factory
09:30-10:00

Approaching medical cannabis policies in the context of emerging technologies

Graham De Barra

10:00-10:30

How medical cannabis companies are tackling IP concerns in the US

Dave Rodman

10:30-11:00

Using Cannabis is my business, not yours: Trusted information in a Trustless Environment.

Alex Cahana

11:00-11:30

Solving connectivity in the global hemp trade market

Kenneth Reece

Workshop by BDO - Understanding Malta’s Medical Cannabis Regulation expand icon

Hosted by:

09:30-10:00

Tea / Coffee Networking

10:00-10:20

Introduction / Regulation in Malta

Mark Attard

10:20-10:40

Application Process

Luke Attard

10:40-11:15

Tax Advisory

Josef Mercieca

11:15-11:45

Legal Considerations

Giannella Barbieri

11:45-12:00

Panel discussion

12:00-12:15

Q&A

12:15-13:00

Pre-lunch networking drinks at the BDO stand

Facilitating Taxation & Transparency with Blockchain Technology expand icon

14:00-14:30

How blockchain solutions can solve the regulatory issues for medical cannabis

Raja Sharif

14:30-15:00

Blockchain and cannabis - Taxes, transparency and self-regulation

Alex Migitko

15:00-15:30

Cryptocurrency for Cannabis: RSU-Arthit Coin

Chetneti Srisa-an

ARE YOU A START-UP?
Fill in the Cannabiz
Start-Up Pitch
application form.
APPLY TODAY!
BECOME A SPEAKER
We’re always looking to collaborate
with thought leaders who are willing to shape the
medical cannabis industry.
SUBMIT
BOOK PASS TODAY!
Grab a ticket!
Low fees for all delegates.
Find out now.
BOOK YOUR PASS!